Delayed Coronary Obstruction After TAVR: A Complication We Had Not Considered

Delayed coronary obstruction (after TAVR, outside the cath lab) is a rare complication with high mortality rates, not unlike acute obstruction. Cardiologists should be expectant and, upon the slightest suspicion of this complication, patients should be brought back to the cath lab for a coronary angiography.

Transcatheter Valve Replacement in the Bicuspid Valve Is Increasingly Performed, but Challenges RemainOcclusion immediately after implant release has been well-studied and described (risk factors, prevention techniques, more akin devices, etc.), but we ignored that this event can take place even months after the procedure.

 

Data for this work were retrospectively collected from an international multicenter registry between 2005 and 2016.

 

During the study period, 38 delayed coronary obstructions (incidence 0.22%) were observed after TAVR from a total of 17,092 patients. Occlusions were more common after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and in cases in which self-expandable valves were used during the index procedure (0.36% vs. 0.11% for balloon-expandable; p < 0.01).


Read also: Permanent Pacemaker: still TAVR’s Aquila’s Heel.


Delayed occlusion was most frequent within 24 hours from the procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 hours and 7 days, and the remaining 14 (36.8%) occurred within 60 days.

 

The most frequent presentation was cardiac arrest (31.6%), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was the culprit vessel in most cases (92.1%).

 

Stent implantation in this registry was successful in about 70% of all patients, thus indicating that angioplasty should be attempted whenever possible.


Read also: Which Low-Flow, Low-Gradient Patients Benefit from Valve Replacement?


In-hospital mortality reached 50% and was higher among patients who experienced the event within 7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).

 

Conclusion

Delayed coronary occlusion following TAVR is a rare phenomenon with an extremely high mortality rate. Angioplasty should be attempted whenever possible, since stent implantation was successful in about 70% of all cases.

 

Original title: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.

Reference: Richard J. Jabbour et al. J Am Coll Cardiol 2018;71:1513-24.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

AHA 2025 | CLOSURE-AF: Left Atrial Appendage Occlusion (LAAO) vs. Medical Therapy in Atrial Fibrillation with High Stroke and Bleeding Risk

Atrial fibrillation (AF) is a complex condition in which patients often present with multiple comorbidities, including high bleeding risk. Percutaneous left atrial appendage occlusion...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

TCT 2025 | ANDES Trial: Short-Term DOAC vs. DAPT After Percutaneous Left Atrial Appendage Occlusion

Percutaneous left atrial appendage occlusion (LAAO) is an established alternative to chronic anticoagulation in patients with non-valvular atrial fibrillation (AFib). A clinically relevant complication...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...